Skip to content Go to the main menu Go to the search form Go to the footer menu
Back to news

Harmonix named winner of the 2025 Golden Ticket

Share the article
Harmonix named winner of the 2025 Golden Ticket

As a Golden Ticket winner, Harmonix will have access to shared laboratories and various Spartners resources for one year. Harmonix will also benefit from a network of Servier mentors and experts, as well as essential operational support to expedite the development of select innovative projects.

00:00 / 00:00

Spotlight on Harmonix: Addressing an unmet need in central nervous system diseases

Harmonix stands out for its commitment to filling a critical medical need in the treatment of central nervous system diseases. A major obstacle hindering the treatment of these diseases is the blood-brain barrier (BBB), which blocks 98% of molecules, including gene therapies, from reaching the brain. Gene therapy targets genetic abnormalities at their source, offering immense potential for treating diseases previously considered incurable. Harmonix is tackling this challenge head-on through the development of innovative solutions to deliver these therapies to the central nervous system, bringing hope for a healthier future.

This award grants the winning startup one year of residency at Spartners, the startup incubator housed within our R&D Institute in Paris-Saclay. The initiative is designed to support and drive forward promising life sciences projects, providing the winning start-up with resources, mentoring, and access to a network of industry experts.

Unique in France, Spartners by Servier & BioLabs is an independent start-up incubator hosted by our R&D Institute in Paris-Saclay. The 1,850 m² facility is equipped to accommodate more than 100 researchers at the heart of a major European ecosystem. Spartners provides shared and private laboratories, fully appointed with state-of-the-art facilities, allowing selected residents to work independently and take advantage of the finest equipment to boost their development.

Servier’s Research and Development Institute in Paris-Saclay

Read more